ARTICLE | Company News
XTL & Dyax in drug discovery deal
January 22, 2001 8:00 AM UTC
XTL Biopharmaceuticals (LSE:XTL) and Dyax (DYAX) will use their drug discovery platforms to discover human antibodies to certain fungal and cancer targets. DYAX will use its phage display technology f...